Lilly to acquire Centessa for $6.3 billion to expand sleep disorder treatments
Eli Lilly and Company (NYSE: LLY) announced a definitive agreement to acquire Centessa Pharmaceuticals plc (NASDAQ: CNTA) for $38.00 per ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
